TimesSquare Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-40,000
| Closed | -$2.05M | – | 250 |
|
|
2017
Q1 | $2.05M | Sell |
40,000
-158,800
| -80% | -$8.14M | 0.01% | 241 |
|
|
2016
Q4 | $7.44M | Buy |
198,800
+3,000
| +2% | +$112K | 0.05% | 223 |
|
|
2016
Q3 | $13.3M | Buy |
195,800
+15,600
| +9% | +$1.06M | 0.09% | 216 |
|
|
2016
Q2 | $10M | Buy |
180,200
+19,150
| +12% | +$1.06M | 0.07% | 214 |
|
|
2016
Q1 | $10.1M | Buy |
161,050
+400
| +0.2% | +$25.1K | 0.07% | 212 |
|
|
2015
Q4 | $15.1M | Sell |
160,650
-19,150
| -11% | -$1.8M | 0.1% | 210 |
|
|
2015
Q3 | $14.4M | Buy |
179,800
+26,700
| +17% | +$2.15M | 0.09% | 213 |
|
|
2015
Q2 | $18.4M | Buy |
153,100
+23,200
| +18% | +$2.78M | 0.1% | 213 |
|
|
2015
Q1 | $13.6M | Buy |
129,900
+500
| +0.4% | +$52.2K | 0.07% | 224 |
|
|
2014
Q4 | $12.6M | Sell |
129,400
-225,550
| -64% | -$21.9M | 0.07% | 218 |
|
|
2014
Q3 | $27.7M | Sell |
354,950
-35,900
| -9% | -$2.8M | 0.16% | 193 |
|
|
2014
Q2 | $24.7M | Sell |
390,850
-7,600
| -2% | -$480K | 0.13% | 200 |
|
|
2014
Q1 | $26.8M | Sell |
398,450
-204,450
| -34% | -$13.7M | 0.14% | 194 |
|
|
2013
Q4 | $38.8M | Sell |
602,900
-19,900
| -3% | -$1.28M | 0.2% | 172 |
|
|
2013
Q3 | $39.9M | Buy |
+622,800
| New | +$39.9M | 0.22% | 163 |
|